by RNA | Sep 21, 2023 | RNA Team News, Valuation Advisory
RNA Advisors, LLC, a leading valuation and strategic advisory services firm focused exclusively in life sciences and healthcare technology, announced today that Scott Winder has joined the firm’s Valuation Advisory Services Group as a Managing Director. Based in the... Read More
by RNA | Jan 9, 2023 | Valuation Advisory
Since 2015, RNA Advisors has provided valuation, transactional and strategic advisory support services to over 300 life science and healthcare services clients totaling over $65 billion in asset and transaction value. Our clients include top-tier venture-backed... Read More
by RNA | Apr 20, 2022 | Client Success, Strategic Advisory, Valuation Advisory
By Jeff Williamson THE SITUATION: A healthcare company with a portfolio of products in development for treating cardiac conditions was fielding investor interest for a potential acquisition. The company wanted to weigh the relative merits of raising additional equity... Read More
by RNA | Apr 20, 2022 | Client Success, Valuation Advisory
By Jeff Suchocki, CFA The Situation: Adoption of ASC 842 – Lease Accounting is mandatory for all private companies for fiscal years beginning after December 15, 2021. To comply with this mandatory adoption requirement, a privately held, clinical stage biotech company... Read More
by RNA | Nov 10, 2020 | Client Success, Strategic Advisory, Valuation Advisory
THE PROBLEM: A healthcare technology company that sells its FDA 510(k) approved device and supporting dashboarding and analytic tools to hospitals was in the midst of a capital raising effort involving a one-on-one negotiation with an existing strategic partner. The... Read More
